Company profile
Novatim Immune Therapeutics
Novatim Immune Therapeutics develops innovative, affordable cancer immunotherapies to address unmet clinical needs.
- Industry
- Biotechnology Research
- Employees
- 3
Novatim Immune Therapeutics company summary
Novatim Immune Therapeutics is a company in the Biotechnology Research industry. On LinkedIn the company has around 3 employees.
What technology does Novatim Immune Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Novatim Immune Therapeutics
Established in 2018, Novatim Immune Therapeutics (Zhejiang) Co., Ltd. operates with Tinova (Shanghai) as its wholly-owned subsidiary, Focusing on pioneering advancements in cancer treatment, Novatim is dedicated to the research and clinical application of innovative cancer immunotherapy. Grounded in clinical needs, Novatim strives to achieve innovative breakthroughs in discovering both first-in-class and best-in-class drugs. Specializing in cancer immunotherapy research, Novatim harnesses three key platforms: the Bifunctional Antibody Platform, the Nano Dual Antibody ADC Platform, and the Enhanced Dual Target CAR-T Platform. 10 FIC/BIC products were developed based on Novatim's technological breakthroughs.
Compare companies similar to Novatim Immune Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Novatim Immune Therapeutics novatim-zj.com | Biotechnology Research | 3 | - | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Novatim Immune Therapeutics
What does Novatim Immune Therapeutics do?
Established in 2018, Novatim Immune Therapeutics (Zhejiang) Co., Ltd. operates with Tinova (Shanghai) as its wholly-owned subsidiary, Focusing on pioneering advancements in cancer treatment, Novatim is dedicated to the research and clinical application of innovative cancer immunotherapy. Grounded in clinical needs, Novatim strives to achieve innovative breakthroughs in discovering both first-in-class and best-in-class drugs. Specializing in cancer immunotherapy research, Novatim harnesses three key platforms: the Bifunctional Antibody Platform, the Nano Dual Antibody ADC Platform, and the Enhanced Dual Target CAR-T Platform. 10 FIC/BIC products were developed based on Novatim's technological breakthroughs.
How many employees does Novatim Immune Therapeutics have?
Novatim Immune Therapeutics has around 3 employees on LinkedIn.
Build a lead list from companies like Novatim Immune Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.